Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
39,736,842
-
Total 13F shares
-
9,423,837
-
Share change
-
-47,753
-
Total reported value
-
$8,730,840
-
Price per share
-
$1.05
-
Number of holders
-
25
-
Value change
-
-$432,476
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) as of Q2 2024
As of 30 Jun 2024,
AEON Biopharma, Inc. - Class A Common Stock (AEON) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,423,837 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., Atalaya Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Formidable Asset Management, LLC, Davidson Kempner Capital Management LP, STATE STREET CORP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.